Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT) (SELECT)

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Alexandra Salvarrey, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00462995
First received: April 17, 2007
Last updated: May 26, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)